Concepedia

Publication | Closed Access

Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer

978

Citations

11

References

2017

Year

Abstract

Development of irAEs was associated with survival outcome of nivolumab treatment in patients with advanced or recurrent NSCLC. Further studies are needed to confirm our findings.

References

YearCitations

Page 1